title: Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus.
abstract: OBJECTIVE
  The aim of this study was assess serum ischemia modified albumin (IMA) in type 2 diabetes patients and determine its correlation with other risk factors for chronic complications such as inflammation and hyperglycemia.
  
  
  METHODS
  Fasting glucose, glycated albumin, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, creatinine, uric acid, albumin, lactic acid, high-sensitivity C-reactive protein (hs-CRP) and IMA were measured in 80 patients with type 2 diabetes and 26 controls.
  
  
  RESULTS
  Fasting glucose, glycated albumin, triglycerides, creatinine, IMA and hs-CRP were significantly higher in patients with type 2 diabetes. Correlations were weak but significant between IMA and fasting glucose, IMA and hs-CRP, hs-CRP and HDL cholesterol and hs-CRP and fasting glucose were observed.
  
  
  CONCLUSIONS
  We have shown higher levels of IMA and hs-CRP in type 2 diabetes. Hyperglycemia and inflammation reduces the capacity of albumin to bind cobalt, resulting in higher IMA levels.
authors.affiliation: Programa de Pós-Graduação em Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.
authors.forename: Michelle
authors.initials: M
authors.lastname: Kaefer
authors.forename: Sílvia J
authors.initials: SJ
authors.lastname: Piva
authors.forename: José A M
authors.initials: JA
authors.lastname: De Carvalho
authors.forename: Dievan B
authors.initials: DB
authors.lastname: Da Silva
authors.forename: Aline M
authors.initials: AM
authors.lastname: Becker
authors.forename: Adriane C
authors.initials: AC
authors.lastname: Coelho
authors.forename: Marta M M F
authors.initials: MM
authors.lastname: Duarte
authors.forename: Rafael N
authors.initials: RN
authors.lastname: Moresco
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D002097:C-Reactive Protein / Q000378:metabolism; D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D005215:Fasting / Q000097:blood; D005260:Female; D017127:Glycation End Products, Advanced; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000150:complications*; D007249:Inflammation / Q000150:complications*; D007511:Ischemia / Q000097:blood / Q000150:complications*; D008297:Male; D008875:Middle Aged; D012709:Serum Albumin / Q000378:metabolism*; D000093423:Glycated Serum Albumin
chemical_list: D001786:Blood Glucose; D017127:Glycation End Products, Advanced; D012709:Serum Albumin; D002097:C-Reactive Protein; D000093423:Glycated Serum Albumin